Comparative genomics on ROR1 and ROR2 orthologs

被引:3
|
作者
Katoh, M
Katoh, M
机构
[1] Natl Canc Ctr, Res Inst, Genet & Cell Biol Sect, Chuo Ku, Tokyo 1040045, Japan
[2] M&M Med BioInformat, Hongo 1130033, Japan
关键词
bioinformatics; comparative genomics; comparative proteomics; WNT; stem cell genomics; integrome network;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transmembrane proteins with extracellular Frizzled domain, such as ROR1, ROR2, MUSK, MFRP, FZD1, FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD8, FZD9 and FZD10, are key molecules for WNT signaling network. Here, comparative integromics analyses on ROR1 and ROR2 orthologs were performed by using bioinformatics. Zebrafish ror2 gene, consisting of nine exons, was identified within CR450684.3 genome sequence. CV490605.1 EST corresponded to the 5'-end of zebrafish ror2 mRNA, and BM533602.1 EST corresponded to the 3'-end. Zebrafish ror2 gene was found to encode a 939-aa transmembrane protein, showing 71.7% and 56.2% total amino-acid identity with human ROR2 and ROR1, respectively. Immunoglobulin-like domain, Frizzled domain, Kringle domain within the extracellular region, tyrosine kinase domain, Ror homology C-terminal (RORHC) domain and juxta-C-terminal LLGD motif within the cytoplasmic region were conserved among vertebrate ROR1 and ROR2 orthologs. SH2 binding site within the RORHC domain was conserved among vertebrate ROR2 orthologs, but not among vertebrate ROR1 orthologs. ROR1 mRNA was expressed in embryonic stem (ES) cells, infant brain; renal cancer, and colon cancer. ROR2 mRNA was expressed in parathyroid, testis, uterus, and also in diffuse type gastric cancer with signet ring cell features. ROR2 promoter rather than ROR1 promoter was more evolutionarily conserved. WNT5A and ROR family receptors, co-expressed in ES cells and gastric cancer, are implicated in the planar cell polarity (PCP) pathway. ROR1 and ROR2 are the pharmacogenomics targets in the fields of stem cell biology and oncology.
引用
收藏
页码:1381 / 1384
页数:4
相关论文
共 50 条
  • [41] ROR2 Expression in Breast Cancer
    Guo, X.
    Sweeny, P.
    Varma, S.
    Montgomery, K.
    West, R. B.
    van de Rijn, M.
    [J]. MODERN PATHOLOGY, 2013, 26 : 45A - 45A
  • [42] Ror2 as a Therapeutic Target in Cancer
    Debebe, Zufan
    Rathmell, W. Kimryn
    [J]. PHARMACOLOGY & THERAPEUTICS, 2015, 150 : 143 - 148
  • [43] Mutations in Ror1 and Ror2 genes cause modification of hydrogen peroxide accumulation in mlo-barley under attack from the powdery mildew fungus
    Hueckelhoven, Ralph
    Trujillo, Marco
    Kogel, Karl-Heinz
    [J]. MOLECULAR PLANT PATHOLOGY, 2000, 1 (05) : 287 - 292
  • [44] ROR1 amplification and overexpression in ovarian cancer
    Miller, Carl
    Walsh, Christine
    Xu, Xuan
    Lu, Quingjie
    Ong, Katy
    Karlan, Beth
    Orsulic, Sandra
    [J]. CANCER RESEARCH, 2009, 69
  • [45] Defining Signaling Interactomes Involved in Non-Canonical Wnt Signaling By ROR1 or ROR2 in Hairy Cell Leukemia That Can Influence Cell Morphology and Migration
    Cring, Matthew
    Widhopf, George
    Ghia, Emanuela M.
    Kipps, Thomas J.
    [J]. BLOOD, 2023, 142
  • [46] IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis
    Lin, Weiwei
    Niu, Rui
    Park, Seong-Min
    Zou, Yan
    Kim, Sung Soo
    Xia, Xue
    Xing, Songge
    Yang, Qingshan
    Sun, Xinhong
    Yuan, Zheng
    Zhou, Shuchang
    Zhang, Dongya
    Kwon, Hyung Joon
    Park, Saewhan
    Kim, Chan Il
    Koo, Harim
    Liu, Yang
    Wu, Haigang
    Zheng, Meng
    Yoo, Heon
    Shi, Bingyang
    Park, Jong Bae
    Yin, Jinlong
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [47] IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis
    Weiwei Lin
    Rui Niu
    Seong-Min Park
    Yan Zou
    Sung Soo Kim
    Xue Xia
    Songge Xing
    Qingshan Yang
    Xinhong Sun
    Zheng Yuan
    Shuchang Zhou
    Dongya Zhang
    Hyung Joon Kwon
    Saewhan Park
    Chan Il Kim
    Harim Koo
    Yang Liu
    Haigang Wu
    Meng Zheng
    Heon Yoo
    Bingyang Shi
    Jong Bae Park
    Jinlong Yin
    [J]. Nature Communications, 14
  • [48] ROR1: A novel target in endometrial cancer
    Liu, Dongli
    Gunther, Kate
    Daniels, Benjamin
    O'Mara, Tracy
    Tang, Katrina
    Ford, Caroline
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [49] ROR1 expression is not a unique marker of CLL
    Barna, Gabor
    Mihalik, Rudolf
    Timar, Botond
    Toemboel, Judit
    Csende, Zsolt
    Sebestyen, Anna
    Boedoer, Csaba
    Csernus, Balazs
    Reiniger, Lilla
    Petak, Istvan
    Matolcsy, Andras
    [J]. HEMATOLOGICAL ONCOLOGY, 2011, 29 (01) : 17 - 21
  • [50] Intratumoral heterogeneity of oncofetal antigen ROR1
    Yamazaki, Masaya
    Ito, Takaaki
    Yamaguchi, Tomoya
    [J]. CANCER SCIENCE, 2021, 112 : 363 - 363